| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453081C Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479486 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/15/2009 | WO2009009727A2 Ghrh analogs and therapeutic uses thereof |
| 01/15/2009 | WO2009008461A1 Pharmaceutical composition for disease caused by proliferation of sex hormone sensitive cell |
| 01/15/2009 | WO2009007987A1 An improved process for the preparation of alfuzosin and its novel polymorph |
| 01/15/2009 | WO2009007348A2 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 01/15/2009 | WO2009006732A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 01/15/2009 | US20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine |
| 01/15/2009 | US20090018190 Compositions and Methods for Transdermal Oxybutynin Therapy |
| 01/15/2009 | US20090018181 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017133 Pharmaceutical formulation comprising lanthanum compounds |
| 01/15/2009 | US20090017111 Tolterodine bead |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017019 Methods and compositions for modulating bmp-10 activity |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | CA2691898A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014292A2 Fenoldopam for treatment of acute renal failure |
| 01/14/2009 | EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder |
| 01/14/2009 | EP2012778A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 01/14/2009 | EP2012775A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
| 01/14/2009 | EP2012769A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101342293A Traditional Chinese medicine preparation for strengthening waist and nourishing kidney |
| 01/14/2009 | CN101342281A Medicine for treating prostatosis and method for preparing same |
| 01/14/2009 | CN101342230A Radix astragali particle and quality control method thereof |
| 01/14/2009 | CN101342220A Method for preparation of decoction for treating prostatitis |
| 01/14/2009 | CN101342216A Medicine for curing prostatitis and preparation method thereof |
| 01/14/2009 | CN101342191A Method for preparation of ícure of urinemia in half a monthí |
| 01/14/2009 | CN101341979A Health beverage and preparation method |
| 01/14/2009 | CN101341960A Concentrated tomato processing technique |
| 01/14/2009 | CN100451018C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/14/2009 | CN100450510C Medicine for treating enuresis and preparation method thereof |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 01/09/2009 | CA2593623A1 The applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor |
| 01/08/2009 | WO2009006413A1 Substituted pyrrolidines |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | US20090012178 Benzoxazocines and Their Therapeutic Use |
| 01/08/2009 | US20090012173 Method for treatment of nocturia |
| 01/08/2009 | US20090012161 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
| 01/08/2009 | US20090012159 High purity bases of 3,3-diphenylpropylamino monoesters |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
| 01/08/2009 | US20090011997 Bifunctional hormone and uses thereof |
| 01/08/2009 | CA2692265A1 Amide compounds |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/08/2009 | CA2681813A1 Transcription factor modulating compounds and methods of use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2011489A2 Method to inhibit ischemia and reperfusion injury |
| 01/07/2009 | EP2010509A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | CN101340946A Pharmaceutical combination for the treatment of luts |
| 01/07/2009 | CN101337068A Kidney cell protection function of protease inhibitor and use thereof |
| 01/07/2009 | CN101337055A Medicine for treating renal colic and preparation method thereof |
| 01/07/2009 | CN101337046A Mixture for treating prostatitis |
| 01/07/2009 | CN101336983A Oldenlandia and quality control method of preparation containing oldenlandia |
| 01/07/2009 | CN101336715A Origin-consolidating health-preserving noodle capable of activating kidney cell |